BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26

• Business

  Scholar Rock Appoints Gregory J. Carven, PhD, As Vice President Of Antibody Discovery And Protein Sciences

  November 20, 2014

   · 

  1 min read
• Biotech Bay

  Vantage Health Announces Recent Scientific Updates And Corporate Developments

  November 20, 2014

   · 

  1 min read
• Drug Development

  Mirna Therapeutics, Inc. Presents Interim Phase 1 Data On First-In-Class Microrna-34 Mimic, MRX34, At The 26th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics

  November 20, 2014

   · 

  4 min read
• FDA

  European Commission (EC) Approves Navidea Biopharmaceuticals’s Sentinel Lymph Node Detection Agent Lymphoseek®

  November 20, 2014

   · 

  7 min read
• Deals

  The Rohatyn Group Completes Sale of 36.6% Huvepharma Stake To Advance Properties

  November 20, 2014

   · 

  1 min read
• Business

  California Institute of Technology, City of Hope Collaborate To Advance Scientific Breakthroughs, Medical Research

  November 20, 2014

   · 

  1 min read
• BioMidwest

  Corgenix Medical Corporation Signs Memorandum of Understanding Regarding Settlement Of Litigation And Announces Plan To Adjourn Special Meeting To December 10

  November 20, 2014

   · 

  1 min read
• Drug Development

  Clovis Oncology Release: Initial Data From Ongoing Phase 2 ARIEL2 Study Of Rucaparib In Ovarian Cancer Demonstrate Encouraging Clinical Activity And Safety In Both BRCA Mutant And Brcaness Patients

  November 20, 2014

   · 

  8 min read
• BioMidwest

  Stericycle ExpertSOLUTIONS Release: Recall Challenges Ahead For Medical Device Sector

  November 20, 2014

   · 

  3 min read
• AEterna Zentaris Adds Hollings Cancer Center To Multi-National Phase 3 Trial In Endometrial Cancer

  November 20, 2014

   · 

  6 min read